Pricing Log in Create free account

PepGen, Inc. (PEPG) vs Upstream Bio, Inc. (UPB)

PepGen, Inc. and Upstream Bio, Inc. are both Biotechnology companies. PepGen, Inc. and Upstream Bio, Inc. are of similar size ($184.6M and $175.2M). PepGen, Inc. has the higher net margin (0.00% vs −4,955.7%) and the lower return on invested capital (−2,076.3% vs −1,100.9%). Across the 13 metrics below, Upstream Bio, Inc. leads on 7 and PepGen, Inc. on 6.

Valuation

Metric PEPG UPB Biotechnology median
P/E n/m n/m 8.50
P/S n/m 47.69 9.71
P/B 1.51 0.56 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.65 0.64
EV/Sales n/m (35.05) 9.21
Earnings yield (50.38%) (105.07%) (33.15%)
Free cash flow yield (38.63%) (90.76%) (25.50%)

Profitability

Metric PEPG UPB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (5,382.65%) 0.00%
Net margin 0.00% (4,955.67%) 0.00%
Free cash flow margin 0.00% (4,317.42%) 0.00%
Return on equity (75.45%) (46.05%) (56.36%)
Return on assets (59.06%) (44.61%) (48.04%)
Return on invested capital (2,076.25%) (1,100.93%) 0.00%

Growth

Metric PEPG UPB Biotechnology median
Revenue growth (TTM) — 15.98% 6.02%
EPS growth (last fiscal year) 25.61% 52.33% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric PEPG UPB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.36 27.99 4.72
Net debt to EBITDA 1.64 2.11 0.96

Dividend

Metric PEPG UPB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PEPG UPB Biotechnology median
Market cap 175.22m 184.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack